{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:55:47Z","timestamp":1781661347973,"version":"3.54.5"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018817","name":"LUPUS UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019256","name":"NIHR GOSH BRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtauto.2026.100353","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:46:57Z","timestamp":1770223617000},"page":"100353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["How loss-of-function mutations in IFIH1 contribute to infectious and\/or inflammatory disease \u2013 a systematic review"],"prefix":"10.1016","volume":"12","author":[{"given":"Isabelle","family":"Ince","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Charras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza J.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1295-6179","authenticated-orcid":false,"given":"Christian M.","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jtauto.2026.100353_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012646","article-title":"Reduced expression of IFIH1 is protective for type 1 diabetes","volume":"5","author":"Downes","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100353_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13373","article-title":"IFIH1 loss of function predisposes to inflammatory and SARS-CoV-2-related infectious diseases","volume":"100","author":"Najm","year":"2024","journal-title":"Scand. J. Immunol."},{"issue":"20","key":"10.1016\/j.jtauto.2026.100353_bib3","doi-asserted-by":"crossref","first-page":"13348","DOI":"10.1074\/jbc.M809449200","article-title":"Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes","volume":"284","author":"Shigemoto","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100353_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1073\/pnas.022637199","article-title":"mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties","volume":"99","author":"Kang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jtauto.2026.100353_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cell.2012.11.048","article-title":"Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5","author":"Wu","year":"2013","journal-title":"Cell"},{"issue":"45","key":"10.1016\/j.jtauto.2026.100353_bib6","doi-asserted-by":"crossref","first-page":"18437","DOI":"10.1073\/pnas.1212186109","article-title":"MDA5 assembles into a polar helical filament on dsRNA","volume":"109","author":"Berke","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.jtauto.2026.100353_bib18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00439-021-02300-4","article-title":"IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel disease","volume":"140","author":"Cananzi","year":"2021","journal-title":"Hum. Genet."},{"key":"10.1016\/j.jtauto.2026.100353_bib7","article-title":"Autoimmune disease associated IFIH1 single nucleotide polymorphism related with IL-18 serum levels in Chinese systemic lupus erythematosus patients","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2026.100353_bib8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100353_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171193","article-title":"Association of IFIH1 and pro-inflammatory mediators: potential new clues in SLE-associated pathogenesis","volume":"12","author":"Munroe","year":"2017","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.jtauto.2026.100353_bib10","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M110.182998","article-title":"systemic lupus erythematosus-associated R77H substitution in the CD11b chain of the Mac-1 integrin compromises leukocyte adhesion and phagocytosis","volume":"286","author":"MacPherson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jtauto.2026.100353_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2015.10.002","article-title":"RIG-I-like receptors and autoimmune diseases","volume":"37","author":"Kato","year":"2015","journal-title":"Curr. Opin. Immunol."},{"issue":"SI2","key":"10.1016\/j.jtauto.2026.100353_bib12","doi-asserted-by":"crossref","first-page":"SI210","DOI":"10.1093\/rheumatology\/keac275","article-title":"Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE","volume":"62","author":"Charras","year":"2023","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100353_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-025-01207-7","article-title":"Juvenile-onset systemic lupus erythematosus: recent advances in pathogenesis and treatment","volume":"27","author":"Natoli","year":"2025","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100353_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29493","article-title":"Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China","volume":"96","author":"Wu","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jtauto.2026.100353_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.791348","article-title":"Presence of Anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100353_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/BOR.0000000000000908","article-title":"Anti-MDA5 dermatomyositis: an update from bench to bedside","volume":"34","author":"Fuzzi","year":"2022","journal-title":"Curr. Opin. Rheumatol."},{"issue":"9","key":"10.1016\/j.jtauto.2026.100353_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1371\/journal.pone.0012646","article-title":"Reduced expression of IFIH1 is protective for type 1 diabetes","volume":"5","author":"Downes","year":"2010","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.jtauto.2026.100353_bib19","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2169\/internalmedicine.55.5774","article-title":"Radiological and pathological correlation in Anti-MDA5 antibody-positive interstitial lung disease: rapidly progressive perilobular opacities and diffuse alveolar damage","volume":"55","author":"Chino","year":"2016","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100353_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2026.100353_bib21","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jtauto.2026.100353_bib22","unstructured":"Ensembl. ENSG00000115267 Homo sapiens Gene Summary Ensembl."},{"key":"10.1016\/j.jtauto.2026.100353_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2023","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jtauto.2026.100353_bib24","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.humimm.2010.08.005","article-title":"Loss-of-function mutations E6 27X and I923V of IFIH1 are associated with lower poly(I:C)-induced interferon-beta production in peripheral blood mononuclear cells of type 1 diabetes patients","volume":"71","author":"Chistiakov","year":"2010","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100353_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1084\/jem.20211349","article-title":"Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis","volume":"218","author":"Chen","year":"2021","journal-title":"J. Exp. Med."},{"issue":"31","key":"10.1016\/j.jtauto.2026.100353_bib26","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1073\/pnas.1704259114","article-title":"Severe viral respiratory infections in children with IFIH1 loss-of-function mutations","volume":"114","author":"Asgari","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100353_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/humu.24165","article-title":"The genomic landscape of pediatric rheumatology disorders in the Middle East","volume":"42","author":"Fathalla","year":"2021","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100353_bib28","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/s41467-018-03911-8","article-title":"Analysis of predicted loss-of-function variants in UK biobank identifies variants protective for disease","volume":"9","author":"Emdin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2026.100353_bib30","first-page":"130","article-title":"Recurrent and prolonged infections in a child with a homozygous IFIH1 nonsense mutation","volume":"8","author":"Zaki","year":"2017","journal-title":"Front. Times"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100353_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/jci.insight.157929","article-title":"MDA5-dependent responses contribute to autoimmune diabetes progression and hindrance","volume":"8","author":"Blum","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtauto.2026.100353_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102417","article-title":"Innate inflammation drives NK cell activation to impair treg activity","volume":"108","author":"Dean","year":"2020","journal-title":"J. Autoimmun."},{"issue":"70","key":"10.1016\/j.jtauto.2026.100353_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn6660","article-title":"Human enteric viruses autonomously shape inflammatory bowel disease phenotype through divergent innate immunomodulation","volume":"7","author":"Adiliaghdam","year":"2022","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100353_bib29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4049\/jimmunol.0901245","article-title":"Immunostimulatory RNA blocks suppression by regulatory T cells","volume":"184","author":"Anz","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2026.100353_bib34","first-page":"12","article-title":"IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus","volume":"12","author":"Guney","year":"2023","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100353_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.virol.2010.02.010","article-title":"Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after coxsackievirus infection","volume":"401","author":"H\u00fchn","year":"2010","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.jtauto.2026.100353_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrendo.2016.30","article-title":"Viral infections in type 1 diabetes mellitus--why the \u03b2 cells?","volume":"12","author":"Op de Beeck","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jtauto.2026.100353_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.751341","article-title":"Changes in MDA5 and TLR3 sensing of the same diabetogenic virus result in different autoimmune disease outcomes","volume":"12","author":"Lincez","year":"2021","journal-title":"Front. Immunol."},{"issue":"Suppl 3","key":"10.1016\/j.jtauto.2026.100353_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/dom.12162","article-title":"Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and \u03b2-cell apoptosis","volume":"15","author":"Santin","year":"2013","journal-title":"Diabetes Obes. Metabol."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100353_bib41","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00125-020-05176-7","article-title":"Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?","volume":"63","author":"Mallone","year":"2020","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.jtauto.2026.100353_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1507\/endocrj.EJ13-0222","article-title":"Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes","volume":"60","author":"Tanaka","year":"2013","journal-title":"Endocr. J."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100353_bib70","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.chom.2012.05.003","article-title":"Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"24","key":"10.1016\/j.jtauto.2026.100353_bib71","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2023114462","article-title":"EZH2 inhibition stimulates repetitive element expression and viral mimicry in resting splenic B cells","volume":"42","author":"Kim","year":"2023","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.jtauto.2026.100353_bib72","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1128\/JVI.02634-10","article-title":"The early interferon response to rotavirus is regulated by PKR and depends on MAVS\/IPS-1, RIG-I, MDA-5, and IRF3","volume":"85","author":"Sen","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jtauto.2026.100353_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-222060","article-title":"Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody","volume":"2018","author":"Parperis","year":"2018","journal-title":"BMJ Case Rep."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100353_bib44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/03009742.2017.1334814","article-title":"Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review","volume":"47","author":"Hoa","year":"2018","journal-title":"Scand. J. Rheumatol."},{"issue":"18","key":"10.1016\/j.jtauto.2026.100353_bib45","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.2169\/internalmedicine.2328-18","article-title":"Interstitial lung disease with anti-melanoma differentiation-associated protein 5 antibody: rapidly progressive perilobular opacity","volume":"58","author":"Chino","year":"2019","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100353_bib47","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/rheumatology\/keaa429","article-title":"Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America","volume":"60","author":"Mamyrova","year":"2021","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.jtauto.2026.100353_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.nmd.2015.03.012","article-title":"Respiratory failure as presenting symptom of necrotizing autoimmune myopathy with anti-melanoma differentiation-associated gene 5 antibodies","volume":"25","author":"Jaeger","year":"2015","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100353_bib74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12969-022-00675-w","article-title":"Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review","volume":"20","author":"Stewart","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jtauto.2026.100353_bib75","article-title":"Anti-MDA-5 dermatomyositis with development of drug-mediated necrolytic skin lesions","volume":"8","author":"Case","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"7","key":"10.1016\/j.jtauto.2026.100353_bib53","article-title":"Unveiling the connections between melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis and its potential association with COVID-19: a report of two cases","volume":"16","author":"Abegunde","year":"2024","journal-title":"Cureus"},{"issue":"38","key":"10.1016\/j.jtauto.2026.100353_bib58","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030634","article-title":"Management of dermatomyositis patients amidst the COVID-19 pandemic: two case reports","volume":"101","author":"Cao","year":"2022","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100353_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-022-00271-1","article-title":"COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis with acute respiratory distress syndrome (ARDS) requiring lung transplantation, a case report","volume":"6","author":"Anderle","year":"2022","journal-title":"BMC Rheumatology"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100353_bib60","article-title":"Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis","volume":"4","author":"Kogami","year":"2020","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.jtauto.2026.100353_bib61","first-page":"5163-24","article-title":"New-onset anti-melanoma differentiation-associated gene 5 antibody positive clinically amyopathic dermatomyositis following COVID-19: a case report","author":"Nakanishi","year":"2025","journal-title":"Intern. Med."},{"key":"10.1016\/j.jtauto.2026.100353_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105136","article-title":"MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)","volume":"104","author":"David","year":"2024","journal-title":"EBioMedicine"},{"issue":"1-3","key":"10.1016\/j.jtauto.2026.100353_bib76","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12016-024-09008-z","article-title":"MDA5 is a major determinant of developing symptoms in critically ill COVID-19 patients","volume":"67","author":"Maiti","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100353_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12122800","article-title":"Increased risk of myositis-specific and myositis-Associated autoantibodies after COVID-19 pandemic and vaccination: a Spanish multicenter collaborative study","volume":"12","author":"Garc\u00eda-Bravo","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100353_bib78","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/cts.13434","article-title":"Screening and characterization of myositis-related autoantibodies in COVID-19 patients","volume":"16","author":"Teo","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jtauto.2026.100353_bib56","doi-asserted-by":"crossref","DOI":"10.1620\/tjem.2025.J047","article-title":"Anti-MDA5 dermatomyositis induced by COVID-19 following recombinant SARS-CoV-2 vaccination: a case report","author":"Sumichika","year":"2025","journal-title":"Tohoku J. Exp. Med."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100353_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.1064","article-title":"A case of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated rapidly progressive interstitial lung diseases developed after administration of COVID-19 vaccine and subsequent pneumococcal vaccine","volume":"10","author":"Takahashi","year":"2022","journal-title":"Respirol Case Rep"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100353_bib65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.31138\/mjr.280124.nom","article-title":"New-onset MDA-5 dermatomyositis in a patient following COVID-19 vaccination: a case report","volume":"35","author":"Bolla","year":"2024","journal-title":"Mediterr J Rheumatol"},{"issue":"10","key":"10.1016\/j.jtauto.2026.100353_bib66","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3899\/jrheum.220259","article-title":"Antimelanoma differentiation-associated gene 5 antibody-positive interstitial lung disease after vaccination with COVID-19 mRNA vaccines","volume":"49","author":"Kitajima","year":"2022","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100353_bib67","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1111\/1346-8138.16906","article-title":"A case of anti-MDA5 antibody-positive dermatomyositis with severe necrosis on limbs after COVID-19 vaccination","volume":"50","author":"Nakanishi","year":"2023","journal-title":"J. Dermatol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100353_bib68","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1111\/jdv.18653","article-title":"A case of Anti-MDA5-Positive dermatomyositis after inactivated COVID-19 vaccine","volume":"37","author":"Yang","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100353_bib69","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/mrcr\/rxac064","article-title":"Appearance of anti-MDA5 antibody-positive dermatomyositis after COVID-19 vaccination","volume":"7","author":"Sugimoto","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.jtauto.2026.100353_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108448","article-title":"COVID-19: immunology and treatment options","volume":"215","author":"Felsenstein","year":"2020","journal-title":"Clin. Immunol."},{"issue":"20","key":"10.1016\/j.jtauto.2026.100353_bib37","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3390\/cells14201617","article-title":"The pathogenesis and virulence of the major enterovirus pathogens associated with severe clinical manifestations: a comprehensive review","volume":"14","author":"Liu","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jtauto.2026.100353_bib46","doi-asserted-by":"crossref","unstructured":"Allenbach Y UY, Toquet S, Leroux G, Gallay L, Marquet A, Meyer A, Guillaud C, Limal N, Gagnadoux F, Hervier B, Borie R, Deligny C, Terrier B, Berezne A, Audia S, Champtiaux N, Devilliers H, Voermans N, Diot E, Servettaz A, Marhadour T, Castelain V, Humbert S, Blanchard-Delaunay C, Tieulie N, Charles P, Gerin M, Mekinian A, Priou P, Meurice JC, Tazi A, Cottin V, Miyara M, Grange B, Isra\u00ebl-Biet D, Phin-Huynh S, Bron C, De Saint Martin L, Fabien N, Mariampillai K, Nunes H, Benveniste O. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases. French myositis network, Neurology 2020(95):70-78.","DOI":"10.1212\/WNL.0000000000009727"},{"issue":"10","key":"10.1016\/j.jtauto.2026.100353_bib48","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1093\/rheumatology\/keab108","article-title":"Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: Multicentre study","volume":"60","author":"Yamasaki","year":"2021","journal-title":"Rheumatology"},{"issue":"8540","key":"10.1016\/j.jtauto.2026.100353_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(87)92271-9","article-title":"Dermatomyositis, polymyositis, and Coxsackie-B-virus infection","volume":"1","author":"Bowles","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jtauto.2026.100353_bib50","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-3719","article-title":"Environmental triggers of dermatomyositis: a narrative review","volume":"9","author":"Bax","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jtauto.2026.100353_bib51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00296-021-04819-1","article-title":"Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry","volume":"41","author":"Mehta","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"7988","key":"10.1016\/j.jtauto.2026.100353_bib52","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41586-023-06717-x","article-title":"Autoantibodies against type I IFNs in humans with alternative NF-\u03baB pathway deficiency","volume":"623","author":"Le Voyer","year":"2023","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jtauto.2026.100353_bib54","first-page":"395","article-title":"COVID-19 linked to rise in anti-MDA5 autoimmunity","volume":"20","author":"McHugh","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"issue":"8","key":"10.1016\/j.jtauto.2026.100353_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11926-021-01023-9","article-title":"COVID-19 and myositis: what we know So far","volume":"23","author":"Saud","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jtauto.2026.100353_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1565803","article-title":"Anti-MDA5+ dermatomyositis following SARS-COV-2 infections: a systematic review","volume":"16","author":"Lattarulo","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100353_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.937667","article-title":"Anti-MDA5 antibody linking COVID-19, type I interferon, and autoimmunity: a case report and systematic literature review","volume":"13","author":"Tonutti","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:25:51Z","timestamp":1781659551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909026000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":78,"alternative-id":["S2589909026000067"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100353","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How loss-of-function mutations in IFIH1 contribute to infectious and\/or inflammatory disease \u2013 a systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100353"}}